Welcome to the SoracteLite Non-Surgical Treatment for Benign Prostatic Hyperplasia (BPH) at Canadian Specialist Hospital Dubai. This innovative, micro-invasive procedure offers a cutting-edge solution for patients suffering from BPH, providing significant relief without the need for traditional surgery.
SoracteLite is a revolutionary treatment that utilizes transperineal laser ablation (TPLA) to address the symptoms of BPH. This non-surgical procedure leverages laser energy to reduce the volume of the prostate gland, thereby alleviating urinary symptoms and improving quality of life as a non-surgical BPH treatment.
The SoracteLite procedure involves the percutaneous insertion of optical fibers into the prostate gland via transperineal access. Laser energy is then delivered through these fibers, heating and destroying the targeted prostate tissue. The entire process is guided by ultrasound, ensuring precision and safety.
SoracteLite is specifically designed to treat Benign Prostatic Hyperplasia (BPH), a common condition in older men characterized by the enlargement of the prostate gland. Symptoms of BPH can include:
Frequent urination
Difficulty starting and maintaining urination
Weak urine stream
Urinary retention
Nocturia (frequent urination at night)
SoracteLite offers numerous benefits over traditional surgical methods:
Minimally Invasive: No need for incisions or general anesthesia.
Quick Procedure: The treatment takes only a few minutes.
Fast Recovery: Patients can return to their normal activities shortly after the procedure.
Minimal Pain: Little to no post-treatment pain.
No Erectile Dysfunction: The procedure does not affect erectile function or other reproductive organs.
Effective Results: Significant and lasting reduction in prostate volume and symptoms.
To ensure the highest level of precision and safety, the SoracteLite procedure incorporates advanced diagnostic and monitoring tools:
Ultrasound Guidance: Real-time imaging to guide the insertion of optical fibers and monitor the treatment area.
MRI-US Fusion Imaging: Combines MRI and ultrasound images for enhanced accuracy.
Biopsy Software: Assists in planning and executing the procedure.
Studies have shown that SoracteLite provides significant clinical benefits, including:
Volumetric Reduction: Up to 40% reduction in prostate volume within one year.
Symptom Relief: Improved International Prostate Symptom Score (IPSS), reduced post-urination residue, and enhanced quality of life.
Safety Profile: Low incidence of complications, with most being transient and manageable.
Expert Care: Our team of urology specialists is highly experienced in performing SoracteLite procedures.
State-of-the-Art Facilities: We utilize the latest technology to ensure the best possible outcomes.
Patient-Centered Approach: We prioritize your comfort and well-being throughout the treatment process.
Comprehensive Care: From diagnosis to post-treatment follow-up, we provide holistic care tailored to your needs.
Take control of your prostate health with SoracteLite at Canadian Specialist Hospital Dubai. Contact us today to schedule a consultation and learn more about how this innovative BPH treatment can help you achieve lasting relief from BPH symptoms.
